European Companies Search Engine

EU funding (€11.4M): An innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring Hor2 Dec 2022 EU Research and Innovation programme "Horizon"

Overview

Text

This publication is not available.

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: accelopment Schweiz AG, Zurich, Switzerland.